[Criticism of Norwegian screening study].
Fretheim
Atle
A
D001327:Autoimmune Diseases / Q000276:immunology / Q000401:mortality; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D015997:Neonatal Screening / Q000191:economics; D009664:Norway; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000276:immunology / Q000401:mortality; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000276:immunology / Q000401:mortality; D013921:Thrombocytopenia / Q000276:immunology / Q000401:mortality